1. Home
  2. GROV vs KPTI Comparison

GROV vs KPTI Comparison

Compare GROV & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROV
  • KPTI
  • Stock Information
  • Founded
  • GROV 2016
  • KPTI 2008
  • Country
  • GROV United States
  • KPTI United States
  • Employees
  • GROV N/A
  • KPTI N/A
  • Industry
  • GROV Package Goods/Cosmetics
  • KPTI Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROV Consumer Discretionary
  • KPTI Health Care
  • Exchange
  • GROV Nasdaq
  • KPTI Nasdaq
  • Market Cap
  • GROV 53.5M
  • KPTI 44.5M
  • IPO Year
  • GROV N/A
  • KPTI 2013
  • Fundamental
  • Price
  • GROV $1.47
  • KPTI $6.30
  • Analyst Decision
  • GROV Buy
  • KPTI Buy
  • Analyst Count
  • GROV 2
  • KPTI 6
  • Target Price
  • GROV $1.35
  • KPTI $39.80
  • AVG Volume (30 Days)
  • GROV 101.6K
  • KPTI 204.5K
  • Earning Date
  • GROV 08-07-2025
  • KPTI 08-11-2025
  • Dividend Yield
  • GROV N/A
  • KPTI N/A
  • EPS Growth
  • GROV N/A
  • KPTI N/A
  • EPS
  • GROV N/A
  • KPTI N/A
  • Revenue
  • GROV $185,354,000.00
  • KPTI $137,269,000.00
  • Revenue This Year
  • GROV N/A
  • KPTI $2.18
  • Revenue Next Year
  • GROV $11.10
  • KPTI $11.28
  • P/E Ratio
  • GROV N/A
  • KPTI N/A
  • Revenue Growth
  • GROV N/A
  • KPTI N/A
  • 52 Week Low
  • GROV $1.02
  • KPTI $3.51
  • 52 Week High
  • GROV $1.95
  • KPTI $16.95
  • Technical
  • Relative Strength Index (RSI)
  • GROV 54.99
  • KPTI 67.24
  • Support Level
  • GROV $1.41
  • KPTI $6.02
  • Resistance Level
  • GROV $1.60
  • KPTI $7.01
  • Average True Range (ATR)
  • GROV 0.10
  • KPTI 0.62
  • MACD
  • GROV 0.00
  • KPTI 0.25
  • Stochastic Oscillator
  • GROV 60.23
  • KPTI 78.87

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

Share on Social Networks: